NORTHWEST BIOTHERAPEUTICS INC Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Northwest Biotherapeutics Inc quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Northwest Biotherapeutics Inc Depreciation for the quarter ending March 31, 2024 was $400K, a 33.3% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Depreciation for 2023 was $1.5M, a 15.4% increase from 2022.
  • Northwest Biotherapeutics Inc annual Depreciation for 2022 was $1.3M, a 333% increase from 2021.
  • Northwest Biotherapeutics Inc annual Depreciation for 2021 was $300K, a 245% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.5M +$200K +15.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $1.3M +$1M +333% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $300K +$213K +245% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $87K +$66K +314% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $21K -$1.28M -98.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.3M +$900K +225% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $400K +$211K +112% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-02
2016 $189K +$133K +238% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 $56K +$44K +367% Jan 1, 2015 Dec 31, 2015 10-K 2017-04-17
2014 $12K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.